BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35018785)

  • 1. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
    Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
    Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X; Wang X; Wei L; Liu J; Chen M
    Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of bladder cancer after radiotherapy for prostate cancer.
    Abern MR; Dude AM; Tsivian M; Coogan CL
    Urol Oncol; 2013 Nov; 31(8):1628-34. PubMed ID: 22575239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D; Hetzel JT; Roy H; Rubin DT
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
    Yang J; Wu F; An H; Gan H
    Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.
    Brenner DJ; Curtis RE; Hall EJ; Ron E
    Cancer; 2000 Jan; 88(2):398-406. PubMed ID: 10640974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
    Zhou B; Zang R; Song P; Zhang M; Bie F; Bai G; Li Y; Huai Q; Han Y; Gao S
    J Transl Med; 2023 Jan; 21(1):10. PubMed ID: 36624443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.
    Farioli A; Violante FS; Mattioli S; Curti S; Kriebel D
    Cancer Causes Control; 2013 Aug; 24(8):1535-45. PubMed ID: 23702885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries.
    Li W; Xiao H; Xu X; Zhang Y
    Curr Oncol; 2021 Jan; 28(1):301-316. PubMed ID: 33435562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
    Mo X; Zhou M; Yan H; Chen X; Wang Y
    Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of colon cancer after external radiation therapy for prostate cancer.
    Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
    Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
    Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
    Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
    Berrington de Gonzalez A; Curtis RE; Kry SF; Gilbert E; Lamart S; Berg CD; Stovall M; Ron E
    Lancet Oncol; 2011 Apr; 12(4):353-60. PubMed ID: 21454129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.